4
Views
6
CrossRef citations to date
0
Altmetric
Original Article

The Radiosensitizing and Radioprotective Effect of the Organic Nitroxyl-free Radical TMPN on Extremely Hypoxic Human Cells of Line NHIK 3025, Cultivated in Vitro

, &
Pages 523-534 | Received 20 Oct 1974, Accepted 01 Nov 1974, Published online: 03 Jul 2009
 

Summary

Human cells from the established line NHIK 3025 have been irradiated in suspension under extremely hypoxic conditions (<4 p.p.m. O2) and in presence of the organic nitroxyl-free radical TMPN (2,2,6,6,tetramethyl-4-piperidinol-N-oxyl), at four concentrations, viz. 0·5 mM, 1 mM, 3 mM and 10 mM.

TMPN was found to exhibit both a sensitizing and a protective effect. The sensitizing effect appears at high doses (>400–800 rads, dependent on TMPN-concentration) and increases with increasing TMPN-concentrations.

At low doses (<400–800 rads) TMPN was found to exert a protective effect. Below 300 rads, the protection was found to be optimal for a TMPN-concentration between 0·5 and 3 p.p.m. Within the concentration limits here studied it was found that the dose-range in which TMPN exerts a protection increases with decreasing TMPN-concentration.

The slope of the survival curves was found to increase when the dose exceeded about 2000 rads, irrespective of whether the cells were in contact with 1 mM, 0·5 mM or no TMPN. This suggests that TMPN does not affect the dose-level at which the medium effect appears. (Pettersen, Oftebro and Brustad, 1974.)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.